This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Pulmonary Disease, Chronic Obstructive
and you are
over 40
years old
3
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The study is intended to characterize the lung function profile of BI1744 in COPD patients where patients will perform pulmonary function tests at regular intervals for 24 hours at the end of a 6 week treatment period. Each patient will receive all four treatments.

Provided treatments

  • Drug: BI 1744
  • Drug: bi1744
  • Drug: Placebo
  • Drug: Foradil
Tris trial is registered with FDA with number: NCT00931385. The sponsor of the trial is Boehringer Ingelheim and it is looking for 99 volunteers for the current phase.
Official trial title:
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil Iin Patients With Chronic Obstructive Pulmonary Disease